Search for a command to run...
<italic><bold>Background</bold></italic> In the North-West, a community-based service that combines spirometry with tailored consultant advice has been created. Thousands are reviewed in the service each year, with a large portion receiving normal spirometry results. This service evaluation aims to describe the population in this service with no evidence of airway obstruction that may be suitable for alternative interventions. <italic><bold>Methods</bold></italic> The referral letters, spirometry reports and clinical recommendations of all patients seen in the service between November 2023 and January 2024 were retrospectively reviewed. Demographics, BMI, spirometry and treatment data were collected. <italic><bold>Results</bold></italic> 869 patients were reviewed, of whom 485 had normal spirometry results. The sample was predominantly female (59.6%) and White (59.8%). Median age was 56 (IQR=39-65). The mean eosinophil count was 0.27 (SD=0.172), and the mean FeNO was 22.9 (SD=23.4). 28.2% were current smokers, 35.5% were ex-smokers, and 36.2% were non-smokers. 43.9% (n=213) started treatment before spirometry. Mean BMI was 30.38 kg/m<sup>2</sup> (SD=7.15). 21.4% (n=104) had a BMI>30 and had at least one weight-related comorbidity and, therefore, would be suitable for weight loss drugs such as semaglutide per NICE guidelines (TA875; 2023). <italic><bold>Conclusion</bold></italic> Given the predominance of obesity in the sample with normal spirometry, weight-loss intervention for patients with respiratory symptoms should be considered. Furthermore, a large proportion of patients had been started on treatment for an obstructive airway disease that was not present on spirometry, prompting the need for investigation into these patients to ensure unnecessary medication is not prescribed.